- Healthcare Trust of America stock price today and history
Healthcare Trust of America (HTA) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Healthcare Trust of America stock price, HTA
Healthcare Trust of America stock chart:
Healthcare Trust of America close price: 31.25
Stock price forecast:
DOWN TO -5.44%
Total forecasts: 89
Reached: 51 (57.30%)
Total Win: 37.17 (124.69%)
Showing 1-10 of 513 items.
|Date of Forecast||Stock Price||Target Price||Forecast Reached Date|
Healthcare Trust of America latest news:
Trump, Koch Brothers at Odds Over 'Trumpcare' Vote
Republicans considering whether or not to back U.S. President Donald Trump's healthcare reforms in a crucial House of Representatives vote this week face a painful choice.
GE Health asks EMA to reconsider proposal to stop sale of MRI drug
March 16 (Reuters) - General Electric Co's healthcare
business said it had requested the European Medicines Agency to
reconsider the recommendation made by its panel to suspend the
marketing authorization of certain agents used in MRI scanning.
BRIEF-HBM Healthcare reports 8.14 pct passive stake in ObsEva
* HBM Healthcare Investments (Cayman) Ltd reports a 8.14
percent passive stake in ObsEva SA as of January 25, 2017 - SEC
Further company coverage:
Spicer says there's a difference between WikiLeaks hacks of Podesta, CIA
White House spokesman Sean Spicer on Wednesday said there was a "massive, massive" difference between WikiLeaks' release of Central Intelligence Agency hacking methods and that site's release of former Clinton campaign manager John Podesta's Gmail account. President Trump, during the campaign, had declared, "I love WikiLeaks." "The interest and outrage that occurred last year by a lot of Democrats when it came to leaks, it's interesting that we're hearing not as much outrage now when it comes to national security," Spicer said. On the Republican healthcare bill, Spicer said the amount of affordable healthcare services, not the number of people who obtain health insurance coverage, is the more important metric.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Kindred Healthcare tp halt dividend after March to pay debt, invest in growth
Shares of Kindred Healthcare Inc. (KND) rose more than 4% late Monday after the company said it will halt its dividend after a March dividend payment in order to pay down debt and invest in growth. Kindred said in a statement its board of directors approved a cash dividend of 12 cents a share, payable March 31 to shareholders of record March 13, and has determined that the company's stock trading levels "do not sufficiently reflect the value of the company's quarterly cash dividend."
Tenet Healthcare plunges after wide earnings, forecast miss
Tenet Healthcare Corp. fell 10% in late trading Monday after substantially missing earnings expectations. The hospital operator reported a fourth-quarter loss of $79 million, or 79 cents a share, on revenue of $4.86 billion. After adjustments for restructuring- and acquisition-related costs, as well as other effects, Tenet claimed profit of 6 cents a share. Analysts polled by FactSet expected on average for Tenet to report adjusted earnings of 22 cents a share on sales of $4.96 billion. The company also whiffed on its forecast, projecting first-quarter losses of 45 cents to 60 cents a share on sales of $4.75 billion to $4.95 billion, and full-year profit of $1.05 to $1.30 a share on sales of $19.7 billion to $20.1 billion. Analysts projected first-quarter adjusted profit of 45 cents a share and sales of $4.95 billion for Tenet, and full-year adjusted earnings of $1.97 a share on revenue of $20 billion. Shares decline to less than $20.50 in after-hours action Monday, after closing with a 3.1% gain at $22.67.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-Molina Healthcare to receive $75 mln termination fee following Aetna ending Humana merger
* Molina Healthcare - as result of Aetna ending Humana
merger and plan to sell medicare advantage assets to Molina,
Molina will get $75 million as termination fee
Source text: (http://bit.ly/2knLvt2)
Further company coverage:
Humana to exit Obamacare exchanges, buy back $2B in stock
After its merger with Aetna was called off Tuesday, Humana Inc. said that it will stop offering commercial health insurance to individuals on state exchanges and buy back $2 billion in stock. Humana, which said it is owed a $1 billion breakup fee from Aetna, said it will focus on care for people living with chronic conditions moving forward. The company said it will give up its business of offering individual commercial medical coverage on the 11 state exchanges in which it currently operates as of Jan. 1, 2018. "As an independent company, we will continue to innovate and sharpen our focus on the local healthcare experience of all our members, especially seniors living with chronic conditions," Chief Executive Bruce Broussard said in the announcement. Humana plans to repurchase $2 billion worth of shares, with an accelerated repurchase of $1.5 billion in the current quarter. Humana stock, which closed with a 0.4% decline at $205.97 Tuesday, moved higher to $207 in late trading after the announcement.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Cigna terminates Anthem merger deal, seeks nearly $15 billion in restitution
Cigna Corp. disclosed in filing Tuesday that it has terminated the merger deal with Anthem Inc. , six days after a court ruling to enjoin the proposed merger, and about 19 months after the $48 billion merger was announced. Cigna said has filed suit against Anthem, seeking a $1.85 billion reverse termination fee and more than $13 billion in additional damages, which includes the amount of premium Cigna shareholders did not realize. Cigna said it decided to terminate the deal after a district court found that the merger would decrease competition and choices for consumers. Cigna's decision marked the second big healthcare merger that was terminated Tuesday, after Aetna Inc. and Humana Inc. agreed to end their $34 billion merger, also after 19 months. Cigna said Tuesday that it while it was "disappointed" in the merger's failure, it was moving ahead by expanding its stock repurchase program to a total of $3.7 billion. The company said its 2017 outlook for adjusted earnings growth will get a boost from the "significant" capital available for deployment. Cigna's stock was up 0.4% in afternoon trade, while Anthem shares slipped 0.2%. Over the past 12 months, Cigna's stock has gained 12%, Anthem shares have rallied 34% and the S&P 500 has gained 25%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-ViiV Healthcare announces positive phase III results for two-drug regimen of Dolutegravir and Rilpivirine
* ViiV Healthcare announces detailed positive phase III
results for investigational two-drug regimen of dolutegravir and
rilpivirine for HIV treatment
Siemens considers U.S. listing of healthcare arm: CEO in Euro am Sonntag
German industrial group Siemens is considering listing its $15 billion healthcare business in the United States to take advantage of company valuations that are higher than in Europe, its chief executive told a German newspaper.
BRIEF-Community Healthcare Trust sets quarterly dividend of $0.3875 per share
* Community Healthcare Trust Incorporated Announces
Increased Fourth Quarter Dividend
McKesson to buy CoverMyMeds for $1.1B, reports sales slightly below expectations
McKesson Corp. said late Wednesday it had agreed to buy privately held CoverMyMeds for $1.1 billion, saying the acquisition of the Columbus, Ohio, software company will "strengthen our technology offerings." McKesson also reported fiscal third-quarter sales slightly below Wall Street expectations. The company said it earned $633 million, or $2.86 a share, in the quarter, compared with $634 million, or $2.71 a share, a year ago. Adjusted for one-time items, McKesson earned $3.18 a share in the quarter. Revenue reached $50.1 billion, up 5% from $47.9 billion a year ago, the San Francisco-based company said. Analysts polled by FactSet expected the healthcare services and IT company to report adjusted earnings of $2.91 a share on sales of $50.5 billion. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Abbott gets U.S. antitrust approval to buy St. Jude Medical
WASHINGTON (Reuters) - Healthcare company Abbott Laboratories has won U.S. antitrust approval for its proposed $25 billion acquisition of medical device maker St. Jude Medical Inc , the U.S. Federal Trade Commission said on Tuesday.
Heartland Payment SystemsHPY
Hecla Mining CompanyHL
Hecla Mining CompanyHL^B
Helix Energy Solutions GroupHLX
Helmerich & PayneHP
Hercules Technology Growth CapitalHTGC